Comparative performance of inflammation-based prognostic scores in patients operated for intrahepatic cholangiocarcinoma

References

• Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 2004;40:472–477. doi:10.1016/j.jhep.2003.11.03015123362
   PubMed Web of Science ®Google Scholar
• Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer. 2002;2:10. doi:10.1186/1471-2407-2-1011991810
   PubMed Web of Science ®Google Scholar
• Zou S, Li J, Zhou H, et al. Mutational landscape of intrahepatic cholangiocarcinoma. Nat Commun. 2014;5:5696. doi:10.1038/ncomms669625526346
   PubMed Web of Science ®Google Scholar
• Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268–1289. doi:10.1016/j.jhep.2014.01.02124681130
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Ikeda Y, Korenaga D, et al. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer-Am Cancer Soc. 2005;103:1856–1864.
   PubMed Web of Science ®Google Scholar
• McMillan DC, Canna K, McArdle CS. Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg. 2003;90:215–219. doi:10.1002/bjs.403812555298
   PubMed Web of Science ®Google Scholar
• Kinoshita A, Onoda H, Imai N, et al. Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma. Br J Cancer. 2012;107:988–993. doi:10.1038/bjc.2012.35422878374
   PubMed Web of Science ®Google Scholar
• Pinato DJ, Shiner RJ, Seckl MJ, Stebbing J, Sharma R, Mauri FA. Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer. Brit J Cancer. 2014;110:1930–1935. doi:10.1038/bjc.2014.14524667648
   PubMed Web of Science ®Google Scholar
• Okuno M, Ebata T, Yokoyama Y, et al. Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma. J Gastroenterol. 2016;51:153–161. doi:10.1007/s00535-015-1103-y26187429
   PubMed Web of Science ®Google Scholar
• Wang D, Luo H, Qiu M, et al. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Med Oncol. 2012;29:3092–3100. doi:10.1007/s12032-012-0226-822476808
   PubMed Web of Science ®Google Scholar
• Gomez D, Morris-Stiff G, Toogood GJ, Lodge JPA, Prasad KR. Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol. 2008;97:513–518. doi:10.1002/jso.2100118335453
   PubMed Web of Science ®Google Scholar
• Chen Q, Yang L, Li X, et al. The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy. Tumor Biol. 2015;36:5283–5289. doi:10.1007/s13277-015-3188-6
   PubMedGoogle Scholar
• Chen Q, Dai Z, Yin D, et al. Negative impact of preoperative platelet-lymphocyte ratio on outcome after hepatic resection for intrahepatic cholangiocarcinoma. Medicine. 2015;94:e574. doi:10.1097/MD.000000000000087425837750
   PubMed Web of Science ®Google Scholar
• Edge SB BD CCFA. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.
   Google Scholar
• Ueno S. Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. HEPATOLOGY. 2001;34:529–534. doi:10.1053/jhep.2001.2721911526539
   PubMed Web of Science ®Google Scholar
• Soucek L, Lawlor ER, Soto D, Shchors K, Swigart LB, Evan GI. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med. 2007;13:1211–1218. doi:10.1038/nm164917906636
   PubMed Web of Science ®Google Scholar
• Sparmann A, Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell. 2004;6:447–458. doi:10.1016/j.ccr.2004.09.02815542429
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674. doi:10.1016/j.cell.2011.02.01321376230
   PubMed Web of Science ®Google Scholar
• Roxburgh CS, Salmond JM, Horgan PG, Oien KA, McMillan DC. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg. 2009;249:788–793. doi:10.1097/SLA.0b013e3181a3e73819387324
   PubMed Web of Science ®Google Scholar
• Canna K, McArdle PA, McMillan DC, et al. The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer. 2005;92:651–654. doi:10.1038/sj.bjc.660241915700032
   PubMed Web of Science ®Google Scholar
• Zhou SL, Dai Z, Zhou ZJ, et al. CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils. Carcinogenesis. 2014;35:597–605. doi:10.1093/carcin/bgt39724293410
   PubMed Web of Science ®Google Scholar
• Lin ZY, Liang ZX, Zhuang PL, et al. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels. BMC Cancer. 2016;16:792. doi:10.1186/s12885-016-2827-727733196
   PubMed Web of Science ®Google Scholar
• Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2003;89:1028–1030. doi:10.1038/sj.bjc.660124212966420
   PubMed Web of Science ®Google Scholar
• Proctor MJ, Morrison DS, Talwar D, et al. An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study. Br J Cancer. 2011;104:726–734. doi:10.1038/sj.bjc.660608721266974
   PubMed Web of Science ®Google Scholar
• Proctor MJ, Morrison DS, Talwar D, et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer. 2011;47:2633–2641. doi:10.1016/j.ejca.2011.03.02821724383
   PubMed Web of Science ®Google Scholar
• Mano Y, Shirabe K, Yamashita Y, et al. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma. Ann Surg. 2013;258:301–305. doi:10.1097/SLA.0b013e318297ad6b23774313
   PubMed Web of Science ®Google Scholar
• Jung J, Park SY, Park S, Park J. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma. Tumor Biol. 2015;37:7149–7154. doi:10.1007/s13277-015-4596-3
   Google Scholar
• Shimada H, Takiguchi N, Kainuma O, et al. High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer. 2010;13:170–176. doi:10.1007/s10120-010-0554-320820986
   PubMed Web of Science ®Google Scholar
• Koh C, Bhoo-Pathy N, Ng K, et al. Utility of pre-treatment neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as prognostic factors in breast cancer. Brit J Cancer. 2015;113:150–158. doi:10.1038/bjc.2015.18326022929
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jiang C, Li J, Sun J, Qu X. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma. Clin Transl Oncol. 2015;17:810–818. doi:10.1007/s12094-015-1310-226077119
   PubMed Web of Science ®Google Scholar
• Jiang N, Deng J, Liu Y, Ke B, Liu H, Liang H. The role of preoperative neutrophil–lymphocyte and platelet–lymphocyte ratio in patients after radical resection for gastric cancer. Biomarkers. 2014;19:444–451. doi:10.3109/1354750X.2014.92656724910346
   PubMed Web of Science ®Google Scholar
• Chan AWH, Chan SL, Wong GLH, et al. Prognostic Nutritional Index (PNI) predicts tumor recurrence of very early/early stage hepatocellular carcinoma after surgical resection. Ann Surg Oncol. 2015;22:4138–4148. doi:10.1245/s10434-015-4516-125801356
   PubMed Web of Science ®Google Scholar
• Pinato DJ, North BV, Sharma R. A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI). Br J Cancer. 2012;106:1439–1445. doi:10.1038/bjc.2012.9222433965
   PubMed Web of Science ®Google Scholar
• Okamura Y, Ashida R, Ito T, Sugiura T, Mori K, Uesaka K. Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepatocellular carcinoma. World J Surg. 2015;39:1501–1509. doi:10.1007/s00268-015-2982-z25670038
   PubMed Web of Science ®Google Scholar
• Stotz M, Pichler M, Absenger G, et al. The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer. Brit J Cancer. 2013;110:435–440. doi:10.1038/bjc.2013.78524357796
   PubMed Web of Science ®Google Scholar
• Lin Z. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection. World J Gastroentero. 2015;21:10898. doi:10.3748/wjg.v21.i38.10898
   PubMed Web of Science ®Google Scholar
• Wu S, Lin Y, Ye H, Li F, Xiong X, Cheng N. Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy. J Surg Oncol. 2016;114:202–210. doi:10.1002/jso.2429727199001
   PubMed Web of Science ®Google Scholar
• Szabo G, Mandrekar P, Dolganiuc A. Innate immune response and hepatic inflammation. Semin Liver Dis. 2007;27:339–350. doi:10.1055/s-2007-99151117979071
   PubMed Web of Science ®Google Scholar
• Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141:39–51. doi:10.1016/j.cell.2010.03.01420371344
   PubMed Web of Science ®Google Scholar
• Dunn GP, Old L, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Annu Rev Immunol. 2004;21:137–148.
   Google Scholar
• Hamanishi J, Mandai M, Iwasaki M, et al. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer. Proc Natl Acad Sci U S A. 2007;104:3360–3365. doi:10.1073/pnas.061153310417360651
   PubMed Web of Science ®Google Scholar
• Galon J. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. SCIENCE. 2006;313:1960–1964. doi:10.1126/science.112913917008531
   PubMed Web of Science ®Google Scholar
• Pinato DJ, Stebbing J, Ishizuka M, et al. A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI). J Hepatol. 2012;57:1013–1020. doi:10.1016/j.jhep.2012.06.02222732513
   PubMed Web of Science ®Google Scholar
• Kinoshita A, Onoda H, Imai N, et al. The glasgow prognostic score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma. BMC Cancer. 2013;13:52. doi:10.1186/1471-2407-13-5223374755
   PubMed Web of Science ®Google Scholar